{"anticipatedPostingDate":"2027-03","denomUnitsSelected":"Participants","description":"PFS by investigator assessment is defined as the time from the date of randomization to the date of first documentation of disease progression based on the investigator assessment per RECIST 1.1 or death (whichever occurred first). Data for this outcome measure will be reported after study completion (anticipated study completion date is March 2026).","reportingStatus":"NOT_POSTED","timeFrame":"Up to approximately 69 months","title":"PFS by Investigator Assessment","type":"SECONDARY"}